EMERCOM proceedings: four drugs in a 217 km military field exercise
Comparison in people · 2016
- What was studied
- 320 Belarusian contract servicemen, mean age 21.3, across four treatment groups and placebo.
- Main finding
- During a 217 km, seven-day exercise, the authors report faster recovery with Metaprot and higher circulatory and respiratory reserves with Cortexin.
Related evidence maps: Military & occupational ↗
Reported findings and study design
During a 217 km, seven-day exercise, the authors report faster recovery with Metaprot and higher circulatory and respiratory reserves with Cortexin.
Measurements before the exercise, within 24 hours after return, and three days later. Informed consent and ethics committee approval were reported.
Population or model 320 Belarusian contract servicemen, mean age 21.3, across four treatment groups and placebo.
Dose, route and schedule
A 14-day course began one week before the exercise. Cortexin was reported as 0.4 mg intranasally twice daily. Metaprot, Cytoflavin and Gliatilin were each reported as two tablets twice daily. Tablet strengths and placebo dosing were unspecified.
Protocol source ↗ · Complete institutional conference abstract; printed pp. 172–173.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Metaprot and Cytoflavin · recovery | Faster recovery described | Cytoflavin response was strongest in selected TFAM, PPARA and PPARGC1A genotype groups. |
| Cortexin · circulation and respiration | Higher physiological reserves described | No effect on recovery or basal metabolism was reported. |
| Gliatilin · mobility of nervous processes | Improvement described | No effect on physiological reserves or basal metabolism was reported. |
Conference abstract · treatment arms
| Group | n | Reported administration |
|---|---|---|
| Metaprot (Bemitil) | 61 | Two tablets twice daily |
| Cytoflavin | 63 | Two tablets twice daily |
| Cortexin | 65 | 0.4 mg intranasally twice daily |
| Gliatilin | 66 | Two tablets twice daily |
| Placebo | 65 | Schedule unspecified |
This is a companion report to Pyatibrat’s dissertation. The field exercise contributes no additional participant records.
Source for these results ↗ · Reviewed 2026-11-17
Study limitations and source details
Study limitations
- The abstract gives no effect sizes, allocation or masking details, or adverse-event counts.
- The five arms sum to 320. The dissertation reports 570 overall and Table 49 tabulates 310, including 55 in the Cortexin arm versus 65 here.
Related publications may describe some of the same participants or experiments.
Source details
Original conference abstract · Complete institutional conference abstract; printed pp. 172–173.
Complete institutional conference abstract; printed pp. 172–173.
Reported methods, results and evidence limitations
Sources checked
Added to the library
Citation
A. O. Pyatibrat, S. B. Melnov, E. D. Pyatibrat, P. D. Shabanov. EMERCOM proceedings: four drugs in a 217 km military field exercise Multidisciplinary Clinic of the 21st Century, St Petersburg congress proceedings, pp. 172–173
Related compounds
Bemitil
A synthetic benzimidazole derivative also called bemethyl or Metaprot. Soviet and Russian researchers studied it as an actoprotector, a drug intended to preserve physical work capacity under stress.
Cortexin
A polypeptide extract of animal cerebral cortex. Its active material is a mixture of low-molecular-weight peptides studied in neurological rehabilitation, stroke and pediatric neurology.